Physician profile
Robert Clements
NPI 1063048999
$5,243.29
in general payments reported to CMS, 2019-2025
19 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $2,230 · 2023: $1,061 · 2024: $926 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633 · Long Term Medical Supply Or Device Loan: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.43 |
| Long Term Medical Supply Or Device Loan | $132.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,920.51 | 2022-2025 | Variax, Infinity Adaptis, Inbone |
| Arthrex, INC. | $1,458.08 | 2022 | |
| Smith+Nephew, INC. | $280.15 | 2021-2025 | Collagenase Santyl, Grafix, Grafix Pl |
| Organogenesis INC. | $260.11 | 2023-2025 | Puraply, Novachor, Cygnus Dual |
| Biocomposites INC | $250.66 | 2024-2025 | Stimulan |
| Treace Medical Concepts, INC. | $226.89 | 2022-2025 | |
| Integra Lifesciences Corporation | $199.00 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $137.38 | 2023 | Portfolio |
| Pacira Pharmaceuticals Incorporated | $118.90 | 2021 | |
| Biotissue Holdings INC. | $116.80 | 2022 | |
| Urgo Medical North America, LLC | $56.84 | 2023-2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ossio INC | $51.55 | 2023 | |
| Bone Support INC. | $31.89 | 2025 | Ceramentbone Void Filler, Cerament G |
| Bioventus LLC | $30.24 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $27.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $22.95 | 2025 | Cmf |
| Innovation Technologies INC | $21.43 | 2025 | Irrisept |
| Paratek Pharmaceuticals, INC. | $18.31 | 2025 | Nuzyra |
| Mimedx Group, INC. | $14.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.